Sagimet Biosciences Series A (SGMT) vs Silence Therapeutics Plc American Depository Share (SLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Silence Therapeutics Plc American Depository Share (SLN) has outperformed Sagimet Biosciences Series A (SGMT) over the past year, gaining 91.1% versus a gain of 21.0%. Sagimet Biosciences Series A is the larger company by market cap ($629.7 million vs $610.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SGMT | SLN |
|---|---|---|
| Share price | $8.88 | $9.82 |
| Market cap | $629.67M | $610.35M |
| 1-day change | +1.37% | -0.10% |
| YTD return | +50.00% | +61.51% |
| 1-year return | +20.98% | +91.05% |
| 5-year return | — | -55.00% |
| EPS (TTM) | $-1.29 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.45 | $17.58 |
| 52-week low | $4.50 | $4.19 |
| Distance from 52-week high | -22.44% | -44.13% |
| Average volume | 1.24M | 1.11M |
| Shares outstanding | 70.34M | 62.15M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLN has outperformed SGMT by 70.1 percentage points over the past year.
SGMT vs SLN FAQ
Which is bigger, Sagimet Biosciences Series A or Silence Therapeutics Plc American Depository Share?
Sagimet Biosciences Series A (SGMT) is larger, with a market capitalization of $629.67M compared with $610.35M for Silence Therapeutics Plc American Depository Share (SLN).
Which stock has performed better over the past year, SGMT or SLN?
SLN returned +91.05% over the past 12 months, compared with +20.98% for SGMT (price return, excluding dividends). Past performance does not predict future results.
Are Sagimet Biosciences Series A and Silence Therapeutics Plc American Depository Share in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.